With Memorial Day and the 78th anniversary of D-Day on the horizon, please take a moment to locate the small memorial dedicated to nine local individuals who gave the ultimate sacrifice as part of the Allied invasion of Normandy in June 1944.
In 1972, soon after then-President Richard Nixon’s newly established Frederick Cancer Research Center hired its first employees, 24-year-old Kunio Nagashima put on a suit and tie and boarded a Boeing 747 at Tokyo’s Haneda International Airport. An electron microscopist from Kyoto University, Nagashima had a one-way ticket in his hand, bound for the United States and ready to take a new job—sight unseen.
Women Scientists Advisors (WSA) was established in 1993 and comprises elected representatives from each NIH Institute or Center who volunteer their time to support other female scientists on issues ranging from pay equity to work/family balance and leadership opportunities.
When the pandemic shutdown began in March 2020, offices across NCI at Frederick and the Frederick National Laboratory quickly became ghost towns, as employees packed up and decamped to their newly set-up home offices. But for those engaged in scientific research—including efforts to combat COVID-19 itself—the need to safely work on-site became more critical than ever.
A legacy is one of the grand aspirations in science. Whether it means giving knowledge or advancing the field, every scientist dreams of imparting a meaningful impact in some way. For Bruce Shapiro, Ph.D., NCI at Frederick’s newest scientist emeritus, the dream is a reality. The former senior investigator and section head in the RNA Biology Laboratory of the Center for Cancer Research has officially retired after more than 46 years at the National Institutes of Health. His musings on his career are humble, but his accomplishments are unmistakable.
Our introductions continue and conclude this week. These staff are the core editorial team—the writers, editors, and advisers who produce a variety of articles and oversee the administrative functions of Poster. Whether they’re in the office or working remotely, they’re available to cover the research, operations, events, and people of NCI at Frederick and Frederick National Laboratory. Read on to meet them.
As we begin the 2022 fiscal year and prepare to enter calendar year 2022, we on the editorial team want to take a moment to introduce ourselves to you. First up are our contributing writers, staff in program areas around our institutions who pitch ideas and cover topics related to those groups. Read on to meet them.
Pockets of the NCI at Frederick campus have popped with color the past few months. Staff working on-site may have noticed landscaped flowerbeds boasting arrays of annuals and files of ferns as they passed by larger buildings. The plants were installed thanks to the Campus Improvement Committee, a small group passionate about making a big impact.
Their study started to unravel the riddle of how cancers spread, demonstrating that tumors are comprised of different types of cells, or heterogeneous. Up to this point it was thought that cancer cells in a tumor were identical to each other. The work conducted by husband-and-wife Isaiah (Josh) Fidler, D.V.M., Ph.D., and Margaret Kripke, Ph.D., in Frederick would eventually be recognized as a landmark discovery that redefined the scientific understanding of tumor biology.
George Vande Woude, Ph.D., former director of the Advanced Bioscience Laboratories–Basic Research Program at what is now NCI at Frederick, passed away in April. He was known for being a prudent leader and an outstanding scientist (he and his laboratory discovered the MET oncogene in 1984), as well as for his vibrant personality and seemingly limitless energy.